Editions Ecce Terra CAMPARIS electron GFP microprobe facility Microscopie Confocale

Laboratoire de Microsondes Chromogenic in situ hybridization (CISH) – Microscope Electronique à Balayage

fallback-image

3Mg/Ml Zymosan

Lab Reagents

Human IgG antibody Laboratories manufactures the 3mg/ml zymosan reagents distributed by Genprice. The 3Mg/Ml Zymosan reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other 3Mg/Ml products are available in stock. Specificity: 3Mg/Ml Category: Zymosan

Chemicals information

ML-323

HY-17543 10mM/1mL
EUR 126

ML-098

HY-19800 10mM/1mL
EUR 156

ML-792

HY-108702 10mg
EUR 567

ML-290

HY-112606 5mg
EUR 234

ML-210

HY-100003 10mM/1mL
EUR 161

ML-18

HY-101844 10mM/1mL
EUR 310

ML-030

HY-103050 100mg
EUR 918

ML-336

C3581-10 10 mg
EUR 429
Description: IC50: 32, 20, and 41 nM for TC-83, V3526, and Trinidad donkey strains, respectively.ML-336 is an inhibitor for VEEV-induced cytopathic effect.

ML-336

C3581-25 25 mg
EUR 933
Description: IC50: 32, 20, and 41 nM for TC-83, V3526, and Trinidad donkey strains, respectively.ML-336 is an inhibitor for VEEV-induced cytopathic effect.

ML-336

C3581-5 5 mg
EUR 295
Description: IC50: 32, 20, and 41 nM for TC-83, V3526, and Trinidad donkey strains, respectively.ML-336 is an inhibitor for VEEV-induced cytopathic effect.

ML-211

C3647-1 1 mg
EUR 112
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-10 10 mg
EUR 270
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-25 25 mg
EUR 519
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-5 5 mg
EUR 174
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-265

C4181-10 10 mg
EUR 263
Description: ML-265 (TEPP-46) is a potent and selective PKM2 activator [1][2]. Pyruvate kinase catalyzes the final step in glycolysis and transfers the phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP) to yield adenosine triphosphate (ATP) and pyruvate.

ML-265

C4181-25 25 mg
EUR 463
Description: ML-265 (TEPP-46) is a potent and selective PKM2 activator [1][2]. Pyruvate kinase catalyzes the final step in glycolysis and transfers the phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP) to yield adenosine triphosphate (ATP) and pyruvate.

ML-265

C4181-5 5 mg
EUR 180
Description: ML-265 (TEPP-46) is a potent and selective PKM2 activator [1][2]. Pyruvate kinase catalyzes the final step in glycolysis and transfers the phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP) to yield adenosine triphosphate (ATP) and pyruvate.

Articles récents

septembre 2022
L M M J V S D
 1234
567891011
12131415161718
19202122232425
2627282930  

Catégories

Étiquettes